Page 4,778«..1020..4,7774,7784,7794,780..4,7904,800..»

Stem Cell Trial for MS Approved by FDA – MultipleSclerosis.net

Posted: Published on November 26th, 2013

Stem cell research continues to excite the field of MS research as a new Phase I trial involving the use of stems cells as an Investigational New Drug (IND) in MS patients has been approved by the Food and Drug Administration (FDA). The small Phase I clinical trial will investigate the safety and efficacy of autologous, mesenchymal stems cell-derived neural progenitor cells (MSC-NPs) in the treatment of progressive MS. Neural progenitor cells are cells that can develop into neurons and other nervous system cells, such as oligodendrocytes, encouraging neural repair and regeneration as evidenced in studies with mice (Harris, 2012). Mesenchymal stem cells (MSCs) are adult stem cells derived from bone marrow which can differentiate into other types of cells such as neural progenitor cells (NPCs). Autologous mesenchymal stem cells are obtained from a persons (or animals) own bone marrow. Led by Saud Sadiq, MD and Violaine Harris, PhD, researchers at the Tisch MS Research Center, formerly known as the Multiple Sclerosis Research Center of New York (MSRCNY), will be recruiting approximately 20 progressive MS patients from the existing patient population of the International Multiple Sclerosis Management Practice (IMSMP), which is the research centers clinical practice affiliate in Manhattan, to … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Stem Cell Trial for MS Approved by FDA – MultipleSclerosis.net

69-2.Cerebral Palsy Stem Cell Treatment Case (After Treatment) – boy, 3 years old – Video

Posted: Published on November 26th, 2013

69-2.Cerebral Palsy Stem Cell Treatment Case (After Treatment) - boy, 3 years old Cerebral Palsy Stem Cell Treatment Case (After Treatment) - boy, 3 years old (Foreign nationality) By: Stem Cell … Continue reading

Comments Off on 69-2.Cerebral Palsy Stem Cell Treatment Case (After Treatment) – boy, 3 years old – Video

Stem Cell Therapy – Knee Surgery / Knee Replacement Alternative

Posted: Published on November 25th, 2013

The Regenexx family ofnon-surgical stem cell and blood platelet procedures offer next-generation injection treatments for those who are suffering from knee pain or may be facing knee surgery or knee replacement due to common tendon, ligament and bone injuries, arthritis and other degenerative conditions. A Regenexx patient receives a knee injection using advanced imaging guidance (fluoroscopy) If you have encountered an injury to the knee meniscus, knee cartilage, ACL or MCL ligaments, or have chronic knee pain due to a past injury or osteoarthritis (also known as degenerative joint disease or wear and tear arthritis of the knee), you may be a candidate for a Regenexx stem cell or blood platelet procedure. Traditional options for patients suffering from these issues include arthroscopic knee surgery to repair ligament tears, or total knee joint replacement. With both surgeries, months of rehab are required, and the patient must be aware of and prepared to take on the risks. As a knee surgery or knee replacement alternative, the Regenexx procedures may help alleviate knee pain and the conditions that cause it with a simple office injection procedure. Patients are encouraged to walk the same day, and most experience little to no down time from … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Therapy – Knee Surgery / Knee Replacement Alternative

Basal cell carcinoma – National Library of Medicine – PubMed …

Posted: Published on November 25th, 2013

Basal cell carcinoma is a slow-growing form of skin cancer.A.D.A.M. Skin cancer falls into two major groups: Nonmelanoma and melanoma. Basal cell carcinoma is a type of nonmelanoma skin cancer. Basal cell carcinoma, or basal cell skin cancer, is the most common form of cancer in the United States. Most skin cancers are basal cell cancer. Basal cell carcinoma starts in the top layer of the skin called the epidermis. Most basal cell cancers occur on skin that is regularly exposed to sunlight or other ultraviolet radiation. This includes the top of your head, or scalp. Basal cell skin cancer is most common in people over age 40. However, it occurs in younger people, too. You are more likely to get basal cell skin cancer if you have: Light-colored or freckled skin Blue, green, or grey eyes Blond or red hair Many moles View post: Basal cell carcinoma - National Library of Medicine - PubMed ... … Continue reading

Posted in Cell Medicine | Comments Off on Basal cell carcinoma – National Library of Medicine – PubMed …

Eating Expired Cranberry Sauce For Epilepsy Awareness (WTH RU EATING ep 8) – Video

Posted: Published on November 24th, 2013

Eating Expired Cranberry Sauce For Epilepsy Awareness (WTH RU EATING ep 8) Eating expired cranberry sauce to raise (purple!) awareness for epilepsy! November is Epilepsy Awareness Month so this is a good time to talk about it. Check... By: FreakEating … Continue reading

Comments Off on Eating Expired Cranberry Sauce For Epilepsy Awareness (WTH RU EATING ep 8) – Video

Parkinson Disease Treatment & Management – Medscape Reference

Posted: Published on November 24th, 2013

Services and Web Sites Covered This policy describes what information may be collected about you when you use the services made available through the WebMD Health Professional Network (as defined below), how this information may be used, how you can control how your information is used and what precautions are taken against unauthorized access or use of your information. The services made available through the WebMD Health Professional Network may be provided in a variety of mediums and devices now known or hereinafter developed including mobile applications, and include without limitation news, reference tools and applications, sponsored programming, personalized content, continuing medical education, communication tools and discussion boards (collectively, the "Services"). You should read the privacy policy of each website that you visit after you leave any of the WebMD Health Professional Network websites. We are not responsible for how other websites treat your privacy once you leave one of our websites. The WebMD Health Professional Network is comprised of several websites: medscape.com, medscape.org and theheart.org (referred to collectively as the "Professional Sites"), including any mobile optimized versions of the Professional Sites and the Medscape Mobile Device Application ("Medscape Mobile"). These properties are owned and operated by our affiliated companies. … Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson Disease Treatment & Management – Medscape Reference

David Gracias – Department of Chemical and Biomolecular …

Posted: Published on November 24th, 2013

Education Post-Doctoral Fellow,Harvard University. 1999 - 2001 Ph.D., University of California at Berkeley. 1994 - 1999 5-yr integrated M.S., Indian Institute of Technology (IIT), Kharagpur. 1989 - 1994 Research Interests The Gracias laboratory develops new methods to fabricate very small devices and integrated structures, and characterize these systems using microscopy and spectroscopy. A major thrust of our research is focused on constructing miniaturized 3D devices which are especially challenging to fabricate at small size scales. We are also particularly interested in understanding, synthesizing and characterizing self-assembling, intelligent and hybrid biotic-abiotic systems. We utilize a range of experimental techniques including photo-, e-beam and nano-imprint lithography; thin film deposition, molding, etching, culture of prokaryotic (E coli) and eukaryotic (e.g. fibroblasts, islets, myoblasts) cells, biological assays (e.g. fluorescent stains, ELISA, cytology), non-linear optical spectroscopy, electron microscopy (TEM & SEM with fixation), RF measurements such as GHz spectrum analysis, electrochemical methods such as potentiometry and chronoamperometry and four point electrical testing with femto-amp resolution. We also utilize analytical methods as well finite element methods (HFSS, Surface Evolver, COMSOL) to model data. Our lab is multidisciplinary and students in our lab have had backgrounds in Chemical and Biomolecular Engineering, Electrical Engineering, Physics, Chemistry, Materials Science, … Continue reading

Posted in Femtomedicine | Comments Off on David Gracias – Department of Chemical and Biomolecular …

Diagnostic, Medical Aesthetic, Ophthalmic & Surgical Equipment …

Posted: Published on November 24th, 2013

> Click to read our letter of announcement Effective August 12th, 2013 our address & contact information will change to the following: New Mailing Address: 5050 Dufferin Street, Unit 111 Toronto, ON M3H 5T5 New Phone: (416) 736-3553 New Toll-Free: 1-855-736-3003 New Fax: (416) 736-3554 At Salient Medical Solutions, we offer a wide variety of products, including diagnostic equipment, surgical and medical aesthetic technologies for dermatology, ophthalmology, otolaryngology, gynecology, phlebology and urology.Joined by reputable manufacturers, we are well positioned to provide the best products, quality and service to our valued clients. Salient offers a comprehensive set of turnkey aesthetic solutions, including a variety of ablative and non-ablative medical devicesand professional skin care lines. Each product is carefully selected based on proven safety & efficacy, substantiated by rigorous use and scientific testing. With a variety of best of breed aesthetic devices, we are able to successfully meet the unique requirements of every client. We survey the global industry and carefully select only the best technologies, previously unavailable to the Canadian market. As a total service provider, we offer tools designed to help our clients market their practice, including printed materials, artwork, advertising templates, consumer based websites and more. See more here: … Continue reading

Posted in Femtomedicine | Comments Off on Diagnostic, Medical Aesthetic, Ophthalmic & Surgical Equipment …

Dr Parwez Hossain | University of Southampton

Posted: Published on November 24th, 2013

Research Interests Currently, Parwezs research activity is focused finding new approaches to manage corneal disease. Corneal infections are a major cause of visual impairment worldwide. In the UK alone, 6000 patients are affected from corneal microbial infections every year. Bacterial organisms such Pseudomonas aeroginosa are major causative agents in pathogenesis. Visual impairment often is very rapid (within 24 hours) and frequently leads to permanent visual loss (Figure 1). A common problem during such infection is the severe levels of corneal tissue damage. We know from animal models, that this results from the combined effects from the actions of the pathogen and the hosts inflammatory process. The cornea quickly loses its normal transparency, leading to visual impairment. Since the cornea is a thin structure (human central cornea thickness is only 550m), tissue damage carries high risks of ocular perforation and visual loss. Although antimicrobial therapies are usually successful in reducing the pathogen load, they do not help to limit tissue damage. Currently, there is no effective treatment to limit this. Such therapies are highly desirable since patients would benefit from reduced effects of uncontrolled tissue damage. Parwez has set-up a clinical and laboratory investigative programme, to investigate how different pathogens interact … Continue reading

Posted in Femtomedicine | Comments Off on Dr Parwez Hossain | University of Southampton

The Best of Ophthalmology…..EyeWorld News Magazine

Posted: Published on November 24th, 2013

Femto lasers: At a glance Femtosecond lasers for use in cataract surgery offer more precise and reproducible capsulorhexis Differences in the platforms comes from how they opt to image the cataract Femtosecond lasers for cataract surgery can also be used to create LRIs Using the femtosecond laser in cataract surgery allows for easier emulsification of the cataract Three different platforms all promise better safety, efficacy, and consistency Using lasers to perform certain parts of cataract extraction harkens back to the days when Nd:YAG for posterior capsulotomy was first introduced. These days, the interest in using lasers has increased, as three companies are developing or have brought femtosecond technology to the cataract surgeon. These new lasers have the means of not only removing the cataract, but of creating precise capsulorhexis and treating astigmatism via limbal relaxing incisions. The three companies working on these lasers are: LenSx Lasers (Aliso Viejo, Calif.), LensAR (Winter Park, Fla.), and Optimedica (Santa Clara, Calif.). EyeWorld spoke with the medical monitors or key investigators here in the U.S. about their roles in the development of these lasers. At this point, only the LenSx has clinical indications cleared by the Food and Drug Administration (FDA). The remaining two … Continue reading

Posted in Femtomedicine | Comments Off on The Best of Ophthalmology…..EyeWorld News Magazine

Page 4,778«..1020..4,7774,7784,7794,780..4,7904,800..»